About Syntropic Medical™

Built on a belief that depression is reversible.

Syntropic Medical™ is a medical device company developing a new class of treatment for Major Depressive Disorder. We are building the evidence base, regulatory pathway, and clinical infrastructure to make neuroplasticity therapy a standard of care.

Our name comes from the concept of syntropy: the tendency of living systems to move toward greater order, complexity, and vitality. This is what we are helping restore in the brain.

Investors

We welcome conversations with aligned investors.

Syntropic Medical™ is building a new treatment category in neuroscience. We are advancing a rigorous clinical programme, a clear regulatory pathway, and a platform with reach well beyond Major Depressive Disorder.

We are open to conversations with investors who understand the medtech development cycle, value evidence-based de-risking, and are interested in the intersection of neuroscience, mental health, and scalable medical devices.

If that describes you, we would like to speak.